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INTRODUCTION 
         Diabetes Mellitus is a group of metabolic diseases characterised by 
chronic hyperglycemia associated with abnormal metabolism of proteins fats and 
carbohydrates due to absolute or relative insulin deficiency
13
. 
                                   Diabetes is a modern day epidemic affecting around 366 
million people globally as per 2011 statistics.  India, our country is the diabetic capital 
of the world harbouring more than 60 million people
13,14
. 
                               As the understanding of Diabetes Mellitus has greatly 
improved now , patients are living longer ,making them susceptible to long term 
complications such as neuropathy,nephropathy, retinopathy, and vasculopathy. Each 
complication need to be addressed specifically in addition to hyperglycemia. 
  Diabetic neuropathy is one of the commonest complication of diabetes 
mellitus and is associated with considerable morbidity and  mortality. Autonomic 
neuropathy, often overlooked, is one of the most insidious complications of diabetes 
mellitus (DM) especially if long standing and poorly controlled. Cardiovascular 
autonomic neuropathy (CAN), within the context of Diabetic autonomic neuropathy, 
occurs when there is an impairment of autonomic control of the cardiovascular system 
after ruling out other causes of dysautonomia
5
. However, symptomatic CAN (CAN) 
manifests in about 5% of diabetic patients, but when present, it is associated with the 
increased mortality , predisposing to ventricular arrhythmias, silent ischaemia, and 
cardiac arrest. Hence, its early detection and early prevention is essential.  
             Cardiac Autonomic Neuropathy (CAN) is often overlooked both in 
diagnosis and treatment simply because there is no widely accepted single approach to 
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its diagnosis. Currently, Cardiovascular autonomic reflex tests (CART) are the gold 
standard for diagnosing CAN in persons with DM .It include four tests: (i)heart rate 
variation to deep breathing (ii) heart rate variation to Valsalva, (iii.)heart rate response 
to standing (30:15), and (iv) orthostatic hypotension (OH)
20
. Maneuvers used in the 
first three tests induce changes in heart rate variability that primarily assess the 
parasympathetic ANS. In contrast, Orthostatic hypotension  or the variation in systolic 
BP in supine and standing positions evaluates the function of the sympathetic ANS 
.But these tests  are cumbersome and not easy to perform in every patient.  Therefore, 
there is a need of simple, non-invasive bed side test to detect early autonomic 
involvement in diabetes.  
              In 1980 an association of prolonged QT interval with CAN was 
established .This opened the possibility of rapid objective method to detect cardiac 
dysautonomia. The QTc interval is considered as a measurement of myocardial 
depolarisation and repolarisation, which is influenced by central autonomic neural 
tone and kinetics of myocardial cells. Abnormality of the QT interval which indicates 
abnormal repolarisation has been linked with the development of potentially fatal 
arrhythmias which may lead to sudden death . One potential cause may be severe but 
asymptomatic ischemia, which can induce lethal arrhythmias.  
                          QT is not uniform in all the 12 leads of ECG
9
, which leads to the 
concept of QT dispersion which is the difference between the longest and the shortest 
QT interval on 12 leads ECG strip. QTd also has been shown to be a reliable detection 
method for early abnormalities in autonomic imbalance. So keeping in mind the 
possible role of QTc & QTd on morbidity & mortality in a patient with diabetic CAN, 
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the present study was done to study the relationship of prolonged QTc & QTd with  
CAN in Type 2 diabetes. 
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AIMS AND OBJECTIVES   
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AIM OF THE STUDY  
 
1. To determine QTc maximum, QTc mean , QTc minimum QTc 
dispersion in Type2 diabetic  patients. 
2. Comparison of QTc maximum, QTc minimum, QTc 
dispersion, QTc mean in both study group and control group. 
3. To study the significance of QTd as an indicator of CAN in Type 2 
Diabetes mellitus. 
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REVIEW OF LITERATURE 
1. DIABETES MELLITUS 
                            Diabetes Mellitus is a chronic disease characterised by fasting and 
post prandial hyperglycemia with varied clinical features and progression.  The 
underlying basic mechanism of diabetes is either the defect in the production or 
defect in the action of insulin, which is a hormone that controls metabolism 
of glucose, fat and amino acids
3
. Chronic hyperglycemia from any cause may 
lead to many complications which includes both microvascular and 
macrovascular complications 
1.A. ETIOLOGICAL CLASSIFICATION
3 
 ―The etiological classification of diabetes mellitus currently 
recommended by World Health Organisation and American Diabetes 
Association is given below: 
1. Type 1 diabetes (beta cell destruction, usually leading to absolute insulin 
deficiency) 
A. Immune-mediated 
B. Idiopathic 
II. Type 2 diabetes (may range from predominantly insulin resistance with relative 
insulin deficiency to a predominantly insulin secretory defect with insulin resistance) 
III. Other specific types of diabetes 
A. Genetic defects of beta cell development or function characterized by mutations in: 
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1. Hepatocyte nuclear transcription factor (HNF) 4α (MODY 1) 
2. Glucokinase (MODY 2) 
3. HNF-1α (MODY 3) 
4. Insulin promoter factor-1 (IPF-1; MODY 4) 
5. HNF-1β (MODY 5) 
6. NeuroD1 (MODY 6) 
7. Mitochondrial DNA 
8. Subunits of ATP-sensitive potassium channel 
9. Proinsulin or insulin 
10. Other pancreatic islet regulators/proteins such as KLF11, PAX4, BLK, 
GATA4, GATA6, SLC2A2 (GLUT2), RFX6, GLIS3 
B. Genetic defects in insulin action 
1. Type A insulin resistance 
2. Leprechaunism 
3. Rabson-Mendenhall syndrome 
4. Lipodystrophy syndromes 
C. Diseases of the exocrine pancreas—pancreatitis, pancreatectomy, neoplasia, cystic 
fibrosis, hemochromatosis, fibrocalculous pancreatopathy, mutations in carboxyl ester 
lipase 
D.Endocrinopathies— acromegaly, Cushing‘s syndrome, glucagonoma, 
pheochromocytoma, hyperthyroidism, somatostatinoma, aldosteronoma 
E. Drug- or chemical-induced—glucocorticoids, vacor (a rodenticide), pentamidine, 
nicotinic acid, diazoxide, β-adrenergic agonists, thiazides, calcineurin and mTOR 
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inhibitors, hydantoins, asparaginase, α-interferon, protease inhibitors, antipsychotics 
(atypicals and others), epinephrine 
F. Infections—congenital rubella, cytomegalovirus, coxsackievirus 
G. Uncommon forms of immune-mediated diabetes—‖stiff-person‖ syndrome, anti-
insulin receptor antibodies 
H. Other genetic syndromes sometimes associated with diabetes— Wolfram‘s 
syndrome, Down‘s syndrome, Klinefelter‘s syndrome, Turner‘s syndrome, 
Friedreich‘s ataxia, Huntington‘s chorea, Laurence-Moon- Biedl syndrome, myotonic 
dystrophy, porphyria, Prader-Willi syndrome 
IV. Gestational diabetes mellitus (GDM)‖ 
 
1.B. TYPE 1 DIABETES MELLITUS 
                                     ―Type1 Diabetes Mellitus develops as a result of synergistic 
effects of genetic , environmental and immunologic factors that ultimately destroys 
the pancreatic beta cells .Individuals with genetic susceptibility have normal beta cell 
mass at birth but begin to lose beta cells secondary to autoimmune destruction that 
occur over months to years
3
. A number of auto antibodies are described in type 1 
diabetes which include anti GAD antibodies, anti islet cell antibodies , anti tyrosine 
phosphatase antibodies etc . This autoimmune process is proposed to be triggered by 
environmental or infectious stimulus. Features of diabetes may not become apparent 
until majority of beta cells are destroyed
3
.‖ 
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1.C. TYPE 2 DIABETES MELLITUS 
 ―This represents a heterogenous group of conditions which was previously 
thought to occur in adults, now it is frequently encountered in children and 
adolescents. This disease is characterised by either disorders of insulin action and 
secretion, one of which maybe a dominant problem
7
. When diabetes become clinically 
evident both disorders of insulin action and secretion are present.‖ 
              ― Circulating endogenous insulin is sufficient enough to prevent keto acidosis 
but is inadequate to prevent hyperglycemia especially in the setting of insulin 
resistance. So these patients have a relative but not absolute insulin deficiency. They 
may not require exogenous insulin for their survival but may require insulin for 
glycemic control.‖ 
―Genetic and environmental factors combine to cause insulin resistance 
 and beta cell loss .Early in the disease process, hyperplasia of pancreatic beta cells 
occurs and probably accounts for fasting hyper-insulinism  and exaggerated insulin 
and proinsulin responses to glucose and other stimuli.  With time chronic deposition 
of amyloid in islets may combine with inherited genetic defects progressively to 
impair beta cell function
7
.‖ 
  ―Obesity is the most important factor causing insulin resistance. Visceral 
obesity , due to accumulation of fat in omentum and mesentry correlates with insulin 
resistance. Even those who are not obese may have characteristic centripetal fat 
distribution which confers insulin resistance. Most of Type 2 diabetic patients may 
remain undiagnosed for a long time, mostly in years, because in them classical 
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symptoms of diabetes ie polyuria and polydypsia may not be present due to the 
insidious onset of hyperglycemia
7
 . For the same reason these patients may have 
evidence of neuropathic and cardiovascular complications at the time of diagnosis.‖ 
                   ― The risk of type 2 diabetes increases with age ,BMI, and  physical 
inactivity .Type 2 diabetes shows strong familial aggregation and hence should be 
suspected in people with positive family history . Incidence is also higher in patients 
with other lifestyle diseases like hypertension and dyslipidemia. Diabetes should be 
suspected in women with chronic vulvo-vaginal candidiasis and generalised pruritus. 
Patients with history of gestational diabetes mellitus, with history macrosomia, 
polyhydramnios, pre-eclampsia, unexplained fetal loss are at high risk for developing 
diabetes in later life. Males may present with balanoposthitis
3
.‖ 
1.D. RISK FACTORS FOR TYPE 2 DIABETES MELLITUS
3 
i. ―Family history of diabetes (i.e., parent or sibling with type 2 diabetes) 
ii. Obesity (BMI ≥25 kg/m2 or ethnically relevant definition for overweight) 
iii. Physical inactivity 
iv. Race/ethnicity (e.g., African American, Latino, Native American, Asian 
                American, Pacific Islander) 
v. Previously identified with IFG, IGT, or an hemoglobin A1c of 5.7–6.4% 
vi. History of GDM or delivery of baby >4 kg  
vii. Hypertension (blood pressure ≥140/90 mmHg) or history of CVD 
viii. HDL cholesterol level <35 mg/dL and/or a triglyceride level >250mg/dL 
ix. PCOS‖ 
12 
 
 
 
Figure 1.1. Spectrum of glucose homeostasis and diabetes mellitus. In most types of 
diabetes mellitus individual progresses from normal glucose tolerance to impaired 
glucose tolerance to overt diabetes
3
. 
             
1.E. PATHOGENESIS OF TYPE 2 DIABETES
3,7 
                       ―The pathological sequence of  type 2 diabetes mellitus is complex and 
entails many different elements .There is a strong genetic component. The disease is 
polygenic and multi-factorial as in addition to genetic factors several environmental 
factors modulate the phenotype. The genes that predispose to type 2 DM are 
incompletely identified
15
. Recent genome-wide association studies have identified a 
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large number of genes that convey a relatively small risk for type 2 DM.. The 
mechanisms by which these genetic loci increase the susceptibility to type 2 DM are 
not clear, but most are predicted to alter islet function or development or insulin 
secretion
3,7
. Although the genetic susceptibility to type 2 DM is under active 
investigation , it is currently not possible to use a combination of known genetic loci 
to predict type 2 DM
19
.‖ 
                                       ― As the blood glucose rises above normal, acquired  defects 
in  glucose homeostasis system occurs. It initially impairs beta cell‘s glucose  
responsiveness by impairing the first phase of insulin response, thereby causing blood 
glucose level to rise in the range of impaired glucose tolerance. Hyperglycemia  
together with increased free fatty acids due to obesity and insulin resistance causes  
further deterioration in beta cell function along with insulin resistance causes more 
hyperglycemia ranging to full blown diabetes
3
 .‖ 
                                   ― Type 2 diabetes is thus characterised by hyperinsulinemia, 
insulin resistance, increased hepatic glucose output and impaired fat metabolism. In 
the early stages the blood sugar is maintained normal by hyperinsulinemic response by 
beta cells.So the insulin resistance in type 2 diabetes is relative as it is overcome by 
hyperinsulinemic state. As these progress the beta cells get exhausted and will be 
unable to maintain this hyperinsulinemic state . This leads to decreased peripheral 
utilisation of glucose by the insulin resistant muscle and adipose tissue leading to post 
prandial hyperglycemia
3
. As disease progresses , further decline in insulin secretion 
along with increased hepatic glucose output leads to fasting hyperglycemia and overt 
diabetes.‖ 
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                                                  The molecular mechanism for resistance to insulin is 
still not clear. Its postulated that post receptor defects in insulin regulated 
phosphorylation and dephosphorylation is involved in in resistance . Accumulation of 
lipid within skeletal myocytes impair insulin stimulated mitochondrial ATP 
production
3
 .This leads to impaired fatty acid oxidation and lipid accumulation within 
skeletal myocytes leads to generation of reactive oxygen species and lipid peroxides. 
Hyperinsulinemia induced these effects may be the reason for accelerated 
atherosclerosis seen in diabetics. 
                                                      Central obesity plays a central role in insulin 
resistance. Increased adipocyte mass leads to increased circulating free fatty acids: 
which contribute to insulin resistance. Adiponectin which is an insulin sensitiser is 
reduced in obesity adding on to insulin resistance.In addition these adipokines induces 
an inflammatory state. 
                                         The mechanism behind the beta cell failure is not 
elucidated
3,7
. A second genetic defect in addition to insulin resistance is postulated to 
cause beta cell failure. Glucotoxicity may add on to this causing further beta cell 
failure. Increased hepatic glucose output occurs as a result of insulin resistance and 
hyperinsulinemia leading to decreased glycogen synthesis and storage as well as 
increased gluconeogenesis .The increased circulating free fatty acids may lead to 
increased hepatic synthesis of lipids which may lead on to hepatic steatosis and non 
alcoholic fatty liver disease.            
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Figure1.2:  ―Metabolic changes during the development of type 2 diabetes mellitus 
(DM). Insulin secretion and insulin sensitivity are related, and as an individual 
becomes more insulin resistant (by moving from point A to point B), insulin secretion 
increases. A failure to compensate by increasing the insulin secretion results initially 
in impaired glucose tolerance (IGT; point C) and ultimately in type 2 DM (point D).‖ 
 
1.F. Prevention of diabetes 
   Overt diabetes is preceded by a variable period of impaired glucose tolerance
3,7,13
. 
Life style modifications and pharmacological interventions are suggested to delay the 
onset of DM. Important considerations are maintaining an adequate BMI and regular 
physical activity ie 30 minutes a  day for 5 days a week. Pharmacological measures to 
prevent diabetes is controversial due to lack of supporting data. Currently American 
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Diabetes
3
 association suggested the use of metformin in individuals with IFG and IGT 
and high risk features for development of diabetes like : 
i. age <60years 
ii. BMI>/=35kg/m2 
iii. Family history of diabetes mellitus in first degree relative 
iv. Women with history of GDM 
 
1.G . CRITERIA FOR DIAGNOSIS OF DIABETES MELLITUS
3,13 
i. Symptoms of diabetes plus random blood glucose concentration >/= 
200mg/dl 
ii. Fasting plasma glucose >/=126mg/dl 
iii. Haemoglobin A1C >/= 6.6% 
iv. 2 hour plasma glucose >/= 200mg/dl during an oral glucose tolerance test 
 
1.H .COMPLICATIONS OF DIABETES MELLITUS 
ACUTE COMPLICATIONS OF DIABETES MELLITUS
3 
―Hypoglycaemia , Diabetic ketoacidosis, hyperglycaemic hyperosmolar state are acute 
complications of the disease. Hypoglycemia is seen in both Type 1 and Type 2 
diabetes, when the patient skips a meal. In a previously well controlled Type 2 
diabetes patient if develops hypoglycaemia the physician should rule out the 
development of diabetic nephropathy. DKA is primarily seen in individuals with Type 
1 diabetes Mellitus as they have absolute insulin deficiency which leads to 
ketogenesis. HHS is seen in Type 2 Diabetes mellitus patients where they have 
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enough insulin to prevent ketogenesis but not enough to reduce hyperglycemia  . Both 
are associated with potentially serious complications if not promptly diagnosed and 
treated‖. 
CHRONIC COMPLICATIONS OF DIABETES MELLITUS
3 
I. ―Microvascular 
A. Eye disease 
i. Retinopathy (nonproliferative/proliferative) 
ii. Macular edema 
B. Neuropathy 
i. Sensory and motor (mono- and polyneuropathy) 
ii. Autonomic 
C. Nephropathy (albuminuria and declining renal function) 
II. Macrovascular 
i. Coronary heart disease 
ii. Peripheral arterial disease 
iii. Cerebrovascular disease 
III. Other 
i. Gastrointestinal (gastroparesis, diarrhea) 
ii. Genitourinary (uropathy/sexual dysfunction) 
iii. Dermatologic 
iv. Infectious 
v. Cataracts 
vi. Glaucoma 
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vii. Cheiroarthropathy 
viii. Periodontal disease 
ix. Hearing loss‖ 
 
―Other comorbid conditions associated with diabetes (relationship to hyperglycemia is 
uncertain): depression, obstructive sleep apnea, fatty liver disease, hip fracture, 
osteoporosis (in type 1 diabetes), cognitive impairment or dementia, low testosterone 
in men‖.  
 
MECHANISM OF COMPLICATIONS
3 
                Three major theories are proposed to explain the emergence of 
complications. 
i. ―Increased intracellular glucose via non enzymatic glycosylation of cellular 
proteins, leads to the formation of advanced glycosylation end products 
(AGE‘s)  AGE‘s is thought to cause cross linking of proteins , accelerate 
atherosclerosis ,promote glomerular dysfunction ,reduce nitric oxide synthesis 
,induce endothelial dysfunction and alter the extra-cellular matrix composition 
and structure. 
ii. Hyperglycemia increases glucose metabolism via sorbitol pathway, thus 
converting it to sorbitol by enzyme aldose reductase .Increased sorbitol 
adversely affects cellular physiology and leads to cellular dysfunction. 
19 
 
iii. Hyperglycemia is also proposed to increase formation of diacylglycerol leading 
to activation of certain isoforms of protein kinase C which in turn lead to 
diabetes related complications. 
iv. Hyperglycemia increases the metabolism of glucose via hexosamine pathway 
leading to generation of fructose 6 phosphate. This in turn is a substrate for 
proteoglycan production and glycosylation of proteins leading to 
complications.‖ 
                                         In addition growth factors like VEGF-A, TGF beta 
are also implicated in the pathogenesis of diabetes related complications. Its 
postulated that hyperglycemia leads to increased production of free radicals and 
reactive oxygen species in the mitochondria which may activate the above 4 
pathways. Though hyperglycemia serves as the initial triggering event, the 
different pathogenetic mechanisms involved in the development of different 
complications are still not clearly understood. 
 
2. DIABETIC NEUROPATHY 
                                      ― The clinical impact of diabetes is mainly manifest in the 
peripheral nervous system though CNS is also involved in long standing diabetes. 
Diabetic neuropathy causes substantial morbidity and mortality. It is diagnosed on the 
basis of symptoms and signs, and after the exclusion of other causes of neuropathy as 
the clinical features of diabetic neuropathy are similar to those of other neuropathies
3
. 
Depending on the criteria used for diagnosis, it affects between 50 and 90% of 
patients with diabetes, and of these, 15–30% will have painful diabetic neuropathy 
20 
 
(PDN).Neuropathy occurs secondary to metabolic disturbance, and prevalence is 
related to the duration of diabetes and the degree of metabolic control. As with other 
complications of DM, the development of neuropathy correlates with the duration of 
diabetes and glycemic control. Additional risk factors are body mass index (BMI) , 
smoking. , presence of CVD, elevated triglycerides, and hypertension is also 
associated with diabetic peripheral neuropathy
4
.‖ 
 
2.A . “Classification of diabetic neuropathy3 
i. Somatic 
A.  Polyneuropathy 
a. Symmetrical, mainly sensory and distal 
b. Asymmetrical, mainly motor and proximal (including amyotrophy) 
B.  Mononeuropathy (including mononeuritis multiplex) 
ii. Visceral (autonomic) 
a.  Cardiovascular 
b.  Gastrointestinal 
c. Genitourinary 
d.  Sudomotor 
e. Vasomotor 
f.  Pupillary‖                   
 ―The most common form of diabetic neuropathy is distal symmetric polyneuropathy 
in which loss of function appears in a glove and stocking pattern and is due to axonal 
neuropathic process, but up to 50% of patients do not have symptoms of neuropathy.  
21 
 
Longer nerves are vulnerable and hence more impact is on foot. Both motor and 
sensory nerve conduction is delayed in peripheral nerves and ankle jerk may be 
absent: Sensory involvement precedes motor involvement .Symptoms may include a 
sensation of numbness, tingling, sharpness, or burning that begins in the feet and 
spreads proximally. Pain typically involves the lower extremities, is usually present at 
rest, and worsens at night‖ 
                                    ― Diabetic polyradiculopathy is a syndrome characterized by 
severe disabling pain in the distribution of one or more nerve roots. It may be  
accompanied by motor weakness.The asymmetric neuropathies are distinctive and 
may be due to combination of microvascular, compression and immune mediated 
mechanisms‖. 
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Figure 2.1: Suggested pathogenesis of diabetic neuropathy 
 
2.B . DIABETIC AUTONOMIC NEUROPATHY 
―Autonomic neuropathy is one of the serious and common complication of diabetes. 
DM-related autonomic neuropathy can involve multiple systems, including the 
Cardiovascular, gastrointestinal, genitourinary, sudomotor, and metabolic systems. 
This is not necessarily associated with peripheral somatic neuropathy. Autonomic 
neuropathy may reduce counter-regulatory hormone release, especially 
catecholamines , leading to an inability to sense hypoglycemia  thereby subjecting the 
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patient to the risk of severe hypoglycemia .It further complicates the efforts to 
improve glycemic control. The development of autonomic neuropathy is less clearly 
related to poor metabolic control than somatic neuropathy. So improved glycemic 
control rarely results in improved symptoms.‖ 
 
2.C. Clinical features of autonomic neuropathy 
I. Cardiovascular 
i.  Postural hypotension 
ii.  Resting tachycardia 
iii.  Fixed heart rate 
iv. Exercise intolerance 
II. Gastrointestinal 
i.  Dysphagia, due to oesophageal atony 
ii.  Abdominal fullness, nausea and vomiting, unstable glycaemia, due to 
delayed gastric emptying (‗gastroparesis‘) 
iii. Nocturnal diarrhoea • 
iv. Constipation, due to colonic atony 
v. Fecal incontinence 
III. Genitourinary 
i. Difficulty in micturition 
ii. Urinary incontinence 
iii. Recurrent infection due to atonic bladder 
iv. Erectile dysfunction  
24 
 
v. Retrograde ejaculation 
IV. Sudomotor 
i. Nocturnal sweats without hypoglycaemia 
ii.  Gustatory sweating 
iii. Heat intolerance 
iv. Anhidrosis; fissures in the feet 
V. Vasomotor 
i. Feet feel cold, due to loss of skin vasomotor responses 
ii.  Dependent oedema, due to loss of vasomotor tone and increased vascular 
permeability 
iii. Bullous formation 
VI. Metabolic  
i. Hypoglycaemia unawareness  
ii. Hypoglycaemia associated autonomic  failure 
VII. Pupillary 
i. Decreased pupil size 
ii.  Resistance to mydriatics 
iii.  Delayed or absent reflexes to light 
 
2.D. CARDIVASCULAR AUTONOMIC NEUROPATHY 
                         ―CAN (CAN) is one of the well recognised complication of diabetes 
which carries high mortality and morbidity but is often overlooked both in diagnosis 
and treatment simply because there is no widely accepted single approach to its 
25 
 
diagnosis
5
.  Cardiovascular autonomic neuropathy occurs when there is an impairment 
of autonomic control of the cardiovascular system. It is well known that CAN is an 
early and frequent complication of DM, affecting around 8-15 % of newly diagnosed. 
In addition, CAN is among one of the most disabling complications of DM in terms of 
life expectancy and quality. Clinical manifestations of CAN are pleomorphic and 
appear in late stages. Hence clinical symptoms alone doesn‘t have enough sensitivity 
and specificity for diagnosis
11
. Cardiovascular autonomic involvement can manifest 
clinically as postural hypotension, resting tachycardia, exercise intolerance or may be 
just silent, detected on autonomic function tests‖. 
                                      ―Severity and development of CAN is not all or none 
phenomenon
5
 .It represents a continuous progression of disease .Hence its severity 
was directly related to the duration and degree of high blood sugar levels. Within a 
decade of developing manifest autonomic neuropathy, mortality ranges 30–50% , 
mostly from sudden cardio-respiratory arrest
10
. Patients with postural fall in blood 
pressure have the highest mortality‖.  
                           ―CAN is associated with a high risk of sudden cardiac death, possibly 
related to silent myocardial ischemia and fatal arrhythmias. In patients with diabetic 
autonomic neuropathy there occurs a decrease in parasympathetic tone at night and 
sympathetic activity predominates during sleep. This may be the reason for cardio 
vascular events‖. 
 
 
 
26 
 
2.E. Pathogenesis of CAN 
                        ―Most of the proposed mechanisms of neuronal Injury in diabetes 
mellitus  are based on models of somatic rather than autonomic neuropathy
1
. The 
pathogenesis of CAN is likely involve several mechanisms and pathways that lead 
ischemia of neurons  or direct death or dysfunction of neurons‖.  
i. Hyperglycaemia  
         ―Hyperglycaemia and the adverse metabolic mileu in patients with DM result in 
increased oxidative and nitrosative stress.It  can cause direct neuronal damage as well 
as neuronal and  endothelial dysfunction .The  rich  mitochondria in neuronal axons 
makes them particularly susceptible to  effects on oxidative and nitrosative stress. 
Increased oxidative stress results in poly ADP-ribose polymerase activation. This  
coupled with other activated downstream pathways including the polyol pathway, 
advanced  glycation end products production, protein kinase C and the hexosamine 
pathway are thought to contribute to glucose toxicity. These pathways in return 
exacerbate oxidative stress. These can induce changes in gene transcription factors 
,gene expression: thus  disrupting many cellular functions .This interferes with the 
communication of cell and the extra cellular matrix all of which leads to neuronal 
dysfunction and death
16
.These pathways also result in impaired microvascular-- 
regulation and endothelial dysfunction by different mechanisms, including increase in 
plasminogen activator inhibitor-1 and endothelin- 1 production and impairment of 
endothelial nitric oxide (NO) synthase and NO actions. This can lead to neurovascular 
dysfunction owing to impaired perfusion, and cellular apoptosis‖ 
ii. Autoimmunity 
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iii. Genetic factors 
a. TCF7L2  
b. T393C polymorphism of the gene encoding the Gs-protein-α-subunit (GNAS1)  
iv. Obstructive sleep apnoea  
                           Intermittent hypoxia that occurs in OSA could lead to increased 
oxidative stress, nitrosative stress, and microvascular complications which could lead 
to CAN.CAN inturn can cause changes in upper airways and respiratory drive thus 
predisposing patients to OSA. 
 
2.F. NATURAL HISTORY OF CAN 
                              ―In DM, autonomic nervous system is affected in an ascending  and 
length dependent manner. The vagus nerve, being the longest autonomic nerve it tends 
to be involved early in the course of CAN development. Therefore CAN in early 
stages causes  reduced  parasympathetic activity, which inturn  results in sympathetic 
dominance. This increased sympathetic tone continues up until the late stages of CAN 
.Then in later stages of CAN sympathetic system is also involved‖. 
                            ―CAN is arbitarily divided into 2 stages-a sub-clinical stage and a 
clinical stage. During the sub-clinical stage patient may be asymptomatic and 
diagnosis of CAN needs evaluation of abnormalities in  time and frequency domains 
of the spectral analysis of HRV and the Baroreflex Sensitivity (BRS) tests:as well as 
an increased torsion of the left ventricle .Standard autonomic function tests may be 
normal in this stage‖ 
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                                    ―CAN progresses over time and parasympathetic denervation 
occurs which inturn causes compensatory sympathetic overdrive. This results in 
abnormal CARTs: this stage is followed by development of  symptomatic CAN.The 
time scale required for the progression of subclinical stage to abnormal CART is not 
clear.It is  estimated that most patients with sub-clinical CAN will develop abnormal 
CARTs and features suggestive of cardiac involvement within  almost 5 years of 
developing abnormal time  and frequency domain parameters‖ 
 
 
 
Figure 2.2 : Natural progression of CAN and correlation with clinical signs and   
symptoms 
 
2.G. CLINICAL MANIFESTATIONS OF CAN
1 
i. Resting tachycardia 
                               ―This occurs at a relatively early stage of the disease. A resting 
heart rate of 90-130 beats per minute is observed which is due to reduced 
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parasympathetic tone and increased sympathetic activity . A fixed heart rate ,which 
doesn‘t change with stress or sleep or physical activity  is a sign of complete cardiac 
denervation‖. 
ii. Exercise intolerance 
―CAN causes abnormal blood pressure, heart rate responses to exertion. In later stages 
,due to imbalance between parasympathetic and sympathetic system leads to further 
deterioration of these parameters. This is very important to recognise as exercise 
testing in such individuals may give false negative results‖ 
iii. Orthostatic hypotension 
―Orthostatic hypotension is a manifestation of late stage of CAN; when sympathetic 
denervation also occurs. This occurs as a result of the impairment of the sympathetic 
response to postural change: this is  secondary to poor norepinephrine response and 
abnormalities in the baro-receptor sensitivity, resulting in inadequate HR response and 
peripheral vasoconstriction. Orthostatic hypotension can be aggravated by many 
medications that are commonly used in patients with DM such as diuretics, 
vasodilators, tricyclic antidepressants and insulin. Assessment of resting heart rate and 
orthostatic hypotension carries prognostic significance in patients with autonomic 
neuropathy‖. 
 
iv. Silent ischaemia 
                                           ―Patients with DM and CAN are at high risk for sustaining 
a major cardiovascular event during exertion owing to the limited perception of 
ischemic pain which could delay the appropriate and timely  response to ischemia.  
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The mechanism by which CAN causes silent ischemia is not clear. Mechanisms 
proposed include a) altered pain threshold b) impaired afferent myocardial autonomic 
pathways c) ischaemic processes not detected by routine electrocardiography‖. 
v. Diabetic cardiomyopathy and LV dysfunction 
                                     ―The sympathetic- parasympathetic imbalance observed in the 
early stages of the disease causes a lot of metabolic changes which includes increased 
myocardial catecholamine levels and catecholamine toxicity, which induces 
mitochondrial uncoupling . Such alterations lead to programmed cell death and 
fibrosis ; finally hypertrophy and remodelling of the LV. Important mediators in this 
process are mitochondrial ROS, insulin resistance and calcium dependent apoptosis. 
Diastolic dysfunction in CAN is associated with delayed relaxation and  increased 
stiffness  thus causing impaired filling of the LV. Sympathetic overdrive stimulates 
RAAS, resulting in increased heart rate, cardiac output and peripheral 
vasoconstriction, increased LV wall stress and LV hypertrophy‖. 
 
vi. Mortality/sudden death 
              ―CAN is considered as an independent predictor of mortality and this persists 
despite adequate glycemic control . It highlights the importance of  preventing the 
development of CAN. Sudden cardiac death may be due to silent ischemia or fatal 
arrhythmias‖ . 
Possible factors associated with high mortality are as follows: 
i. Silent myocardial ischemia or infarction 
ii. Cardio-respiratory arrest/ more peri-operative and peri-intubation risk 
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iii. Tachycardia at rest 
iv. Ventricular arrhythmias/prolonged QT interval 
v. Hypertension 
vi. Orthostatic hypotension 
vii. Flattening of nocturnal decrease of BP and heart rate(non dipper) 
viii. Absence of sinus arrhythmia 
ix. Exaggerated BP responses on lying down and with exercise 
x. Abnormal diastolic or systolic LV function 
xi. Poor exercise tolerance 
xii. Impaired cardio vascular responsiveness 
xiii. Intolerance to heat due to defect in the sympathetic thermo-regulation 
xiv. Susceptibility to ulcers of the foot and arteriovenous shunting and 
sudomotor dysfunction leading to amputations 
xv. Hypoglycaemic unawareness 
xvi. Increased risk of severe hypoglycaemia 
xvii. Obstructive sleep apnoea 
 
vii. Peri-operative and intra-operative complications 
viii. Cerebrovascular disease 
ix. Diabetic nephropathy 
―Sympathetic overactivity is proposed to cause tubule-glomerular  
dysfunction in diabetic animal models via a). indirect –hypertension and 
angiotensin and b).direct -vascular smooth muscle proliferation, 
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vasoconstriction, podocytes injury. Nocturnal hypertension causes 
glomerular hypertension and proteinuria. Also CAN is postulated to cause 
erythropoietin defiency‖ . 
x. Lower limb complications 
                                       ―Alterations in microvascular blood flow , impaired 
sudomotor responses , all contribute to dry skin and increased risk of foot ulcers.In 
addition lower limb hyperaemia and inflammation ,owing to sympathetic denervation 
of lower limb vessels contributes to charcot arthropathy‖. 
 
2. H. DIAGNOSIS OF CAN 
i. CARTs 
                                 ― In early 1970s Ewing et al proposed five simple and  
noninvasive tests to measure cardiac autonomic function based on the heart rate  and 
blood pressure response to certain physiological manoeuvres. These tests include:  
(1) HR response to deep breathing 
 (2)HR response to standing, which is expressed as the 30:15 ratio  
(3) HR response to Valsalva manoeuvre  
(4) Blood pressure response to standing 
 (5)Blood pressure response to sustained handgrip 
The first two tests defects in the parasympathetic activity ;while  last two tests  
sympathetic function. The  autonomic changes that occur during the Valsalva 
manoeuvre involve both the sympathetic and parasympathetic systems, although the 
Valsalva ratio mostly represents parasympathetic activity‖. 
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ii. HRV using spectral analysis of sinus arrhhythmia                       
iii. Baro-reflex sensitivity 
                     ―This primarily measures changes in HR in response to changes in 
systolic BP. The test can be performed either with the use of pharmacological methods  
or non-pharmacological techniques. Even subclinical CAN can detected by BRS . 
BRS is now considered as a strong independent risk factor for mortality‖. 
iv. Scintigraphy 
                              ― The use of Single-photon emission computed tomography: 
(SPECT) and/or positron emission tomography  (PET) and sympathetic 
neurotransmitter analogues, such as the 123I-metaiodobenylguanide (123I-MIBG) 
(SPECT), the 11C-metahydroxyephedrine (11C-HED) (PET) and 11C-epinephrine 
has enabled the quantitative scintigraphic evaluation of cardiac sympathetic 
innervations. Cost, radiation exposure and lack of standardisation are limiting 
factors‖. 
v. Muscle nerve sympathetic nerve activity 
                         ―MSNA helps in assessing peripheral sympathetic activity and 
therefore a useful research tool. Cost, time consuming nature and invasiveness are 
limiting factors‖. 
 
vi. Other tests 
a) Arterial stiffness, expressed as carotid femoral wave velocity (PWV) 
b) Catecholamine kinetics 
c) Assessment of cutaneous MBF 
34 
 
d) Intra epidermal nerve fibre density (IENFD) using immune-staining 
 
 
2.I. CRITERIA FOR DIAGNOSIS AND STAGING 
 
                        ―Following the eighth International symposium on diabetic neuropathy 
held in 2010 , CAN subcommittee of the Toronto consensus panel formulated a 
criteria for early diagnosis and staging of CAN: According to this panel : 
i. Possible or early CAN- A single abnormal CART result  
ii. Definite or confirmed CAN-  presence of 2 or 3 abnormal test among the seven 
autonomic cardiovascular indices -5 CARTS, time-domain and frequency-
domain HRV tests 
iii. Severe or advanced CAN- presence of orthostatic hypotension in addition to 
the above criteria  
These tests are cumbersome to perform which necessitates the need of a simple , 
easily reproducible, non invasive bed side test to diagnose early CAN‖. 
 
2. J.  SCREENING FOR CAN
1 
         ―It is very important to recognise CAN at an early stage as its reversible in early 
stages. But most patients with early CAN may be asymptomatic making this a 
difficult task. So the Toronto panel has advised routine screening for CAN‖. 
Who all to be screened?? 
i. Type 2  diabetics at the time of diagnosis 
ii. Type 1 diabetics after 5 years 
iii. Diabetics with other micro or macrovascular complications 
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iv. Patients with poor glycemic control 
v. Diabetics as a part of peri operative assessment 
vi. Diabetics who sustained MI for prognostication 
vii. Diabetics on changing their exercise plan as CAN can affect exercise 
tolerance 
 
2.K. THERAPEUTIC APPROACHES FOR CAN
1 
  ―Treatment approaches are aimed at slowing or reversing the progression of the 
disease in early CAN whereas its aimed at symptom relief in symptomatic CAN. 
i. Life style modification 
Diet modification , moderate degree of aerobic exercise smoking cessation 
and aggressive management of other comorbid conditions are proven to 
improve heart rate variability and delay progression of CAN 
ii. Intensive glycemic control 
iii. Other promising therapies- alpha lipoic acid,GLP 1 agonists , DPP4 
inhibitors, vitamin E, C-peptide 
iv. Blockers of RAAS- ACEI or ARBs or spironolactone or betablocker 
v. Treatment of orthostatic hypotension 
Lifestyle measures-avoiding sudden changes in body posture, avoiding 
precipiting drugs, increased salt and water intake ,physical manoeuvres like 
crossing legs ,squatting 
Pharmacological measures- midodrine, fludrocortisone, somatostatin 
analogues, erythropoietin‖ 
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But none of these measures is satisfactory and management of postural 
hypotension is still difficult . 
2.L. SIGNIFICANCE OF AUTONOMIC FUNCTION TESTING IN TYPE 2 
DIABETICS 
                                   ― Autonomic function testing can contribute to good patient 
management in the following ways: 
i. Assist in emphasizing the need for tight glycemic control 
                       It is observed that early identification and tight glycemic 
control delays the progression of CAN. This is emphasized in DCCT trial 
which says that intensive glycemic control may prevent the further 
deterioration of autonomic neuropathy‖. 
ii. Early initiation of specific treatment 
                        ―Timely identification of autonomic dysfunction helps in 
initiating end organ prophyllaxis such as the use of ACEI, and aspirin and 
the use of pharmacological and non pharmacological measures to improve 
blood pressure and lipid control‖. 
iii. Emphasize the importance of adhering to diet and exercise plans 
                     ― Early detection of autonomic dysfunction enables and 
motivates the patient to adhere to diet and exercise plans which help in 
achieving better glycemic control‖. 
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3. ECG IN CAN 
                          ―CAN is known to be associated with a variety of ECG changes. ECG 
changes in early CAN include tall R wave , increases QTc duration , absence of sinus 
arrhythmia
6
.‖ 
                                        ―CAN is said to be associated with obesity, hyperglycemia, 
long duration of diabetes, hypertension, dyslipidemia, micro-vascular complications 
and smoking. QTc interval prolongation has also been associated  with age, sex, blood 
pressure, BMI, visceral obesity, smoking, the type of diabetes and the duration of 
diabetes. It is likely to be influenced by OHA , degree of glycemic control and 
severity of autonomic neuropathy‖. 
                                       ― The association of prolonged QT interval with CAN was 
proposed in early in 1980
17
. This paved way for a simple bedside objective and easily 
reproducible method to detect CAN.  QTc interval is a reflection of myocardial 
depolarization and repolarization
6
. This in turn is under the  influence of  central 
autonomic neural tone‖. 
                                         ―More recently it is observed that there is inter lead variation 
in QT segment duration –QT dispersion. It is said to represent the regional difference 
in the myocardial recovery from excitability. It is already known that increased QT 
dispersion associated with long QT syndromes, HOCM, CCF, acute MI etc is a major 
cause of sudden cardiac death occurring in such conditions‖. 
                                       ― In diabetes mellitus the autonomic denervation is regional 
and irregular. This leads to variability in QT and QT dispersion increases. Hence QT 
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dispersion along with corrected QT with heart rate is considered as a better marker for 
CAN‖ .  
                                        ―How CAN produces QT prolongation is still not clear. Its 
proposed that sympathetic overdrive following early parasympathetic involvement is 
causing QT prolongation.‖ 
 
3.A QTc interval calculation 
 
 
       Figure 3.1: Normal ECG 
 
                                               ― QT interval represents the total duration of ventricular 
depolarisation and repolarisation. It is measured from the beginning of the Q wave to 
the end of the T wave. Usually the lead with the maximum QT interval and T wave 
amplitude is taken into account
9‖
.  
                                               ―Theoritically QT interval should be same in all the 
standard limb leads but practically it is not so
9,12
. Differences do occur because 
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ventricular projections on different limb leads are different.In precordial leads too QT 
interval may be varying because of the differences in the proximity to the heart and 
also due to local repolarisation duration differences in the sites facing the electrode‖. 
                                               ―The changes in the QT interval with RR interval occurs 
gradually.  So the measured QT represents an instantaneous value only when rhythm 
is regular for several cycles. QT interval includes QRS complex ; but still prolonged 
QRS comples as occurs in bundle branch block doesn‘t interfere with QT 
measurement: but it may interfere with the interpretation .QRS complex duration has  
to be subtracted from the QT interval  to find the JT interval which represents 
ventricular repolarisation independent of depolarisation‖.   
                                                ―The time of QT measurement may also influence its 
measurement
9
. It is observed that QT interval is longer at night and eve. And 
maximum QT interval is said to be present shortly after awakening. This diurnal 
variation with QT is due to the variation in autonomic tone‖.                                                    
                                                Studies also show that QT interval varies between males 
and females. Studies observed three patterns in QT
9
: 
a) Male pattern- j point elevation >0.1mV and ST angle more than 20 
degrees 
b) Female pattern with j point elevation <0.1mV and ST angle < 20 
degrees 
c) Indeterminate pattern with j point elevation >0.1mV and ST angle < 20 
degrees 
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―Studies showed that male pattern predominates in males at puberty and  
by middle age female pattern predominates and there is complete reversal by old age. 
These changes are attributed to the fall in testosterone levels in males as they grow 
old. Testosterone causes shortening of QT interval‖  
                          
Figure 3.2 . Pattern showing QT distribution in females 
 
Figure 3 .3 : Pattern showing QT distribution in males and females 
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                                             ―Twelve-lead ECG was carried out in all the patients with 
paper speed of 25 mm / s by electrocardiography .The QT interval duration was 
manually calculated from the ‗beginning of the Q wave to the end of the T wave‘ in 
all 12 leads. The maximal QT interval duration was measured among these 12 leads‖ 
 
 Figure3.4. A normal ECG strip showing the voltage and duration                 
 
QT intervals were corrected in accordance with the rate using the ‗BAZET‘ formula: 
                                 
  
√  
 
―The corrected QT of 460 milliseconds or more in women and 440 milliseconds or 
more in men was considered as prolonged QT interval. The QT interval represents 
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electrical depolarisation and repolarisation of the ventricles. A lengthened QT interval 
is a marker for the potential of  ventricular tachy-arrhythmias  like torsades de pointes 
and a risk factor for sudden death
9‖
. 
 
       
Figure 3.5.. Normal waves in ECG with their duration.  
 
3.B Correction for heart rate 
―Both R-R interval, the QT interval are dependent on the heart rate (the faster the 
heart rate the shorter the R-R Interval and QT interval).Correction of QT interval is 
necessary to improve the detection of patients at increased risk of ventricular 
arrhythmia. The standard clinical correction is to use ‗Bazett's formula12‖. 
                  
  
√  
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QTcB is the QT interval corrected for heart rate, and RR is the interval from the onset 
of one QRS complex to the onset of the next QRS complex, measured in seconds, QT 
is measured in milliseconds). 
―Fridericia‖  formula an alternative correction formula using the cube-root of RR. 
                
  
√  
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SUMMARY OF PRIOR PUBLICATIONS 
1.  In Heart India, Vol 3 / Issue 1 / Jan-Mar 2015  Pillai and Madhavan published an 
article on ―CAN and QTc Interval in Type 2 diabetes‖ 
                                               This study included fifty patients with Type 2 diabetes 
mellitus with duration more than 5 years . Thirty age and sex-matched controls 
without any history of diabetes were also included in the study . Five autonomic 
function tests were done in all cases and controls to assess CAN. Heart rate, QTc , and 
QTc dispersion were measured and compared among patients and controls. Diabetics 
with autonomic neuropathy had significantly higher QTc mean and QTc max values 
compared to diabetics without autonomic neuropathy and controls. QTc dispersion 
was significantly more among patients with autonomic neuropathy compared to those 
without autonomic neuropathy and controls. 
 
2. JIMSA April-June 2011 Vol. 24 No. 2 S.N. Chugh, P. Mittal, S. Kumar, K. Chugh  
published an article on ―QT Dispersion in Patients of Diabetes Mellitus without  
Manifest Cardiac Dysautonomia‖ 
                                         The objective of this study was to detect the complication in 
diabetic individuals by measuring QT interval and its dispersion. For this 50 diabetic 
patients selected for the study. Cardiac dysautonomia was diagnosed in 25 out of 50 
patients. Further analysis revealed  that severity of CAN correlated with  QT interval 
and dispersion . 
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3. In  JIACM 2006; 7(2): 130-2  ,CP Mathur, Deepak Gupta published an article on 
―QTc Prolongation in Diabetes Mellitus – An Indicator of CAN‖   
                                                    In this study 50 cases of diabetes with stable clinical  
cardiac  status  were subjected to a battery of 5  autonomic function tests to find out 
the incidence of CAN (CAN). 19 cases out of 50  (38%) were found to have  evidence 
of CAN.QTc prolongation was observed in 15 cases.. The study suggested that QTc 
prolongation can be taken as an evidence of CAN in diabetics. 
 
4. In The Egyptian Heart Journal (2014) 66, 63–69 , Wael Refaie published an article 
on the ― Assessment of CAN in long standing type 2 diabetic women‖ 
                                            This study was conducted with the background of patients 
with long standing DM undergoing surgical procedures  are put under great stress  as 
they may have occult cardiovascular involvement and/or CAN (CAN).In this study 
106  Type 2 diabetic mellitus  women scheduled for major surgical procedures were 
assessed by the cardiac autonomic function tests. Continuous 24 hour holter 
monitoring  was done to evaluate  QTc and QTd, arrhythmia ,and ischemia . In the 
study group CAN was diagnosed in 70 %. QTc prolongation and QT dispersion were 
found in many cases. 
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5. In JIMSA Oct. - Dec. 2014 Vol. 27 No. 4; N. S. Neki, Jatinder Kaur  published an 
article on ―A study of QTc-Prolongation and QT Dispersion (QTd) as an indicator of 
CAN (CAN) in type 2 Diabetes Mellitus Patients‖   
                                          This study was done on hundred cases of type-2 diabetes 
mellitus patients , out of which fifty cases were diagnosed to have CAN on the basis 
of standard cardiac autonomic function tests. These reflexes include i). valsalva 
manoeuver ii). Heart rate response to deep breathing, and  iii).  Standing to assess 
parasympathetic function as well as  iv). BP   response  to standing and v). Sustained   
hand grip to assess sympathetic function. Rest of fifty patients not having CAN served 
as healthy controls. ECG was taken for all. The QTc interval  and  QTc dispersion was 
calculated for patients and controls . The study concluded that  QTc prolongation 
showed positive correlation with the degree of CAN.  QTc prolongation in an 
otherwise healthy looking  diabetic patient can be used as a bedside tool for 
assessment of CAN. 
 
6. In Rev Med Chir Soc Med Nat Iasi.2010 Jan –Mar ;114(1);282-6; Matel 
D, Chiochină AD, Stratone A; ―Utility of QTc interval for the diagnosis of CAN in 
type 2 diabetes mellitus‖ 
                                            In this study  65 cases of type 2 diabetes  with no  
evidence of cardiac disease clinically  were subjected to a set  of 5 non-invasive 
autonomic function tests as recommended by Ewing et al ; these included deep 
breathing test, heart rate response to standing  (30:15 ratio), Valsalva ratio, diastolic 
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blood pressure rise with sustained hand grip, and orthostatic hypotension on standing. 
A score of 2 or larger diagnosed CAN. QT interval was calculated from  ECG. The 
corrected QT was determined with Bazett's formula, and a value more than 440 msec 
was considered as prolonged. Prolongation of QTc  was observed in diabetics by 
comparison with control group . Study showed that  QTc was higher in diabetics with 
CAN compared to diabetics without CAN . Hence it was concluded that QTc 
prolongation correlated positively with the severity  of CAN.  
 
7. In Journal of clinical Endocrinology Metabolism 1987 April ;64(4):751-4;Kahn  
JK, Sisson JC, Vinik AI; published an article on ―QT interval prolongation and sudden 
cardiac death in diabetic autonomic neuropathy‖.                
                                                In this thirty among insulin-dependent diabetes mellitus 
patients with no evidence of ischemic heart disease, seventeen patients were found to 
have CAN. The corrected QT interval was measured using Bazett  formula at rest and 
at  peak exercise,and was found to be prolonged (greater than 440 msec) in twelve of 
these patients at rest and in fifteen  at peak exercise. QTc prolongation was found  in 
patients with  CAN. These data also suggest that diabetic CAN  results in 
parasympathetic-sympathetic  imbalance and hence cause  QTc interval prolongation, 
predisposing these patients to sudden arrhythmias and death. 
 
8. Jermendy G, Tóth L, Vörös P, Koltai MZ, Pogátsa G; published an article on  
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―Cardiac  autonomic neuropathy and QT interval length. A follow- up study in 
diabetic patients.‖ 
                                                  The objective of this study was to evaluate the clinical 
significance of QT  prolongation in diabetics with CAN , fifty three  diabetic patients 
were followed up for a period of five years or to death. The results of cardiovascular 
autonomic function tests as well as the QT intervals were determined. It was found 
that QTc intervals were significantly prolonged  in diabetics with definitive CAN 
compared to those with early and those without signs of CAN and  controls. Out of 
53, 13 patients died during the follow-up period .Of those 1 was  without CAN ;2 with 
early CAN and 10 patients with definitive signs of CAN; but QTc intervals were not  
significantly different in  patients with cardiac and non-cardiac causes of death. 
9. Pourmoghaddas A, Hekmatnia A; published an article on ― The relationship 
between QTc interval and CAN in diabetes mellitus.‖ 
                                         This study included two hundred diabetics and 200 non-
diabetic patients . QTc was determined in both case and control group. Then the case 
and control group was compared. It was observed that the prevalence of QTc 
prolongation was significantly more in cases than controls. Parasympathetic 
dysfunction was observed to be more common than sympathetic. The prolonged QT in 
case group predisposed them to ventricular tachyarrhythmias and silent ischemia 
which causes sudden death. The study thus emphasised the need for early 
identification of CAN thus preventing such fatal complications 
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10.  Gonin JM , Kadrofske MM, Schmaltz S, Bastyr EJ 3rd, Vinik AI; published an 
article on ―Corrected Q-T interval prolongation as diagnostic tool for assessment of 
CAN in diabetes mellitus‖. 
                                             In this study 73 diabetic patients comprising 46 insulin 
dependent and 27 non-insulin dependent diabetes mellitus patients taken.  For study 
purpose patients  were separated into four groups based on the presence and severity  
of CAN with the help of non-invasive cardiovascular reflex tests. The patients with  
evidence of ischemic heart disease,  chronic kidney disease, or the idiopathic long Q-
T-interval syndrome were excluded from the study.  ECG was taken to calculate QT 
and corrected QT interval was  with Bazett's formula.It was observed that  diabetic 
patients with more than 2 abnormal CARTs had  longer QTc interval compared to  
those with no evidence of CAN. Diabetic patients with more than one abnormal 
CARTs  had a prolonged QTc interval compared with a control group . 
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I. MATERIALS AND METHODS; 
STUDY POPULATION: 
The study was conducted among patients from General Medicine wards  of  
Government Rajaji Hospital, Madurai during the period of  February 2016 to July 
2016. The aim of the study was to find out the significance of QTd as an indicator of 
CAN in Type 2 Diabetes mellitus. The study included 100 cases of diabetes and 100 
age and sex matched controls. 
 
STUDY GROUP 
The study was conducted among 100 patients of type 2 diabetes mellitus 
diagnosed according to World Health Organization (WHO) criteria, from the 
General Medicine wards of Government Rajaji Hospital , Madurai , from February 
2016 to July 2016.  
INCLUSION CRITERIA: 
i. Onset of diabetes after 30 years and 
ii. Duration more than or equal to 5 years  
 
EXCLUSION CRITERIA:    
i. History of hypertension 
ii. History or electrocardiography (ECG) evidence of coronary artery disease 
iii. Stroke/transient ischemic attack (TIA) 
iv. Electrolyte imbalance like hypokalemia or hypocalcemia 
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v. History of heart failure 
vi. History of renal dysfunction 
vii. History of  hypothyroidism 
viii. Patients on drugs affecting autonomic tone or QT interval  
CONTROL GROUP 
  Age and sex matched 100 controls were selected after getting informed consent. 
The same exclusion criteria was applied to the control group also. 
STUDY DESIGN:   Case control study 
STUDY PERIOD : February 2016 to July 2016 ( 6 months) 
ETHICAL COMMITTEE CLEARANCE- Obtained 
FINANCIAL SUPPORT-Nil 
DATA COLLECTION: 
            A previously designed proforma was used to collect the demographic and 
clinical details of the patients. History regarding symptoms of autonomic neuropathy 
like orthostatic hypotension ,palpitations, exercise intolerance, bladder symptoms, 
diarrhoea, constipation, heat intolerance, sweating, anhydrosis, dry skin, erectile 
dysfunction and female sexual dysfunction was asked for. 
                                         History regarding duration of diabetes and past history of 
hypertension, stroke, Chronic kidney disease, cardiac disease, history of pregnancy or 
lactation, history of any chronic drug intake, family history of diabetes mellitus , 
hypertension, Coronary artery disease were recorded. 
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                                     Clinical examination of height ,weight , blood pressure, heart 
rate , pulse rate, was done for all patients. Body mass index was found out with the 
help of the formula :    
      (  )
      (  )
. ECG was rewcorded for all patients. 
                               Lab investigations like complete hemogram, Renal function tests, 
Liver function tests , urine routine examination, FBS, PPBS ,lipid profile were done. 
 
           A battery of five autonomic function tests are done in all cases to assess CAN. 
A score of 0-2 is assigned to each test. The tests conducted were: 
1. Postural fall in systolic blood pressure (BP) — Systolic BP was measured when 
the patient  lying down and 3 minutes after standing. 
 
A fall of more than 30 mm Hg was abnormal — Score 2 
A fall of 10-29 mmHg was borderline              — Score 1 
A fall less than 10 mmHg                              — normal Score 0 
 
2. Increase in diastolic pressure during hand grip — Hand grip was maintained at 30% 
maximum for 5 minutes. A rise in diastolic BP in the contralateral arm from the value 
obtained before the test was measured. 
 
Rise >16 mmHg — Normal Score 0 
11-15 mmHg     — Borderline Score 1 
<10 mm Hg       — Abnormal Score-2 
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3. Heart rate response to Valsalva manoeuvre—The patient was asked to  forcefully 
exhale into a manometer after closing the nose to raise the pressure to 40 mmHg for 
15 seconds. Ratio of longest RR interval shortly after the manoeuvre to the shortest 
RR interval during the manoeuvre was then measured. This was expressed as Valsalva 
ratio. 
 
Value >1.21 — Normal score 0 
Value 1.11-1.20 - Borderline score 1 
Value ≤1.10 — Abnormal score 2 
 
4. Deep breathing test—Patient was asked to lie supine and breathe 6 times per minute 
and ECG was recoreded. The mean of the differences in maximum and minimum 
heart rate during each breathing cycle for three successive breathing cycles was taken 
to give the maximum minus minimum heart rate. 
 
≥15 beats per minute — Normal Score 0 
11-14 beats per minute — Borderline Score 1 
≤10 beats per minute — Abnormal Score 2 
 
5. Heart rate response to standing — The RR interval was  measured at beats 15 and 
30 after the patient assumes erect posture from horizontal.  Usually a rapid increase in 
heart rate to standing that is maximum at about 15 th beat after standing .This  is 
followed by relative bradycardia which is maximum at 30 th beat after standing. ECG 
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tracings was used to determine the 30:15 ratio , calculated as the ratio of the longest 
RR interval found at beat 30 to the shortest RR interval found at about beat 15 . 
Because the maximum and minimum RR intervals may not always occur at exactly 
the 30 th or 15 th beat after standing , maximum /minimum 30:15 ratio was calculated 
as the longest RR interval during beats 20-40 divided by the shortest RR interval 
during beats 5-25. This was according to the redefinition by Zieger et al. Heart rate 
response to standing was considered abnormal if the patient had orthostatic 
hypotension. 
 
Value ≥1.04        — Normal Score 0 
Value 1.01-1.03 — Borderline Score 1 
Value ≤1.00        — Abnormal Score 2 
 
Total score ranged from 0–10. Based on the score obtained from the test, patients are 
divided in to three groups: 
 
Group 1: Severe autonomic neuropathy — Score >5 
Group 2: Early autonomic neuropathy    — Score 2-4 
Group 3: No autonomic neuropathy       — Score 0-1 
 
A 12 lead ECG is taken after 10 minutes rest in all patients at 50 mm/second speed. 
RR interval, heart rate, QTc interval, QTc maximum, QTc minimum and QTc 
dispersion are calculated from the ECG. 
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QTc (second) = QT (second)/√ RR (seconds) 
QTc mean is calculated from the QTc intervals of all the leads 
QTc dispersion is then calculated by the formula 
QTc dispersion = QTc max (longest QTc) — QTc min (shortest QTc) 
Comparisons of heart rate, QTc mean, QTc max, QTc min, QTc dispersion are made 
in various groups and controls and significance assessed by Students t test. Relation 
between age, sex, and autonomic neuropathy are assessed by Pearson correlation test. 
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RESULTS AND INTERPRETATIONS 
A total of 100 patients were included in the study, from among the patients who got 
admitted in General Medicine wards at Government Rajaji Hospital Madurai. 
I. AGE DISTRIBUTION 
 Most of the patients belonged to the age group 50-60 years, followed by 40-50 
years. The average age for study group was 54 years 
The following table (table 1) shows the age distribution of patients included in the 
study. 
Table 1: Age distribution 
Age in years Cases Controls 
30-40 years 0 0 
40-50 years 34 36 
50-60 years 53 56 
60-70 years 11 7 
above70 years 2 1 
Total 100 100 
Range 42-72 40-70 
Mean 54.12 53.19 
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Figure 1 : Diagram showing age distribution of cases . 100 similar ageand sex 
matched controls were taken for the study. 
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II. SEX  DISTRIBUTION  
Among the 100 patients studied 55 were males and 45 females  
Table 2:Sex distribution 
Sex Number of 
cases 
Number of 
controls 
Males 55 56 
Females 45 44 
Total 100 100 
 
 
Figure 2: Pie diagram showing sex distribution of cases, 100 similar age and sex 
matched controls were taken for the study. 
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III. DURATION OF DIABETES 
 
All the patients in the study group had duration of diabetes more than 5 
years.The cases were divided into 3 groups according to the duration of 
diabetes. 
 
Table 3: Duration of diabetes in study group 
Duration in years  Males  Females  total 
5-10 years 48 33 81 
10-15 years 9 7 16 
>15years 1 2 3 
 
 
 
Figure 3:Diagram showing duration of diabetes among cases. 
0
5
10
15
20
25
30
35
40
45
50
5-10 years 10-15 years >15years
Males
Females
33 
9      7 
48 
 1       2      
2 
63 
 
IV. CAN IN T2DM CASES AND CONTROLS 
 
Among the 100 cases studied 62 had CAN .Of these 62, 44 had Grade 
2(severe) CAN, 18 had Grade1(early) CAN .In the control group 3 had 
Grade1 CAN, which can be attributed to their age. 
Table 4: CAN in T2DM patients and controls 
CAN 
GRADE 
                           CASES                          CONTROLS 
 Males  Females  Total  Males  Females  Total  
Grade0 27 11 38 52 44 96 
Grade1 8 10 18 2 1 3 
Grade2 20 24 44 1 0 1 
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Figure 4:   CAN in cases and controls 
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V. SEVERITY OF DIABETES BASED ON PPBS 
 
The Type 2 Diabetes Mellitus patients were divided into three groups based 
on the PPBS values as mild ,moderate and severe hyperglycemia.76 patients 
had mild hyperglycemia with PPBS values less than 250mg% , while 6 had 
moderate and 18 had severe hyperglycemia with PPBS values between 250-
300mg% and more than 300mg% respectively.  
Table 5: Severity of diabetes based on PPBS 
 
PPBS (mg/dl) NUMBER OF CASES 
Mild (<250mg/dl) 76 
Moderate (250-300mg/dl) 6 
Severe (>300mg/dl) 18 
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VI. MEAN HEART RATE IN TYPE 2 DM CASES AND CONTROLS 
                     
     Mean heart rate was found to be high in diabetic patients compared to 
controls .Among the cases the heart rate was higher in those with severe 
CAN . There was no significant difference in mean heart rate between 
control group and diabetic patients without CAN. 
 
Table 6: Mean heart rate in cases and controls 
Group  Number of patients Mean heart rate 
Cases-Grade 2 CAN 44 92.68 
Cases-Grade 1 CAN 18 76.78 
Cases-Grade 0 CAN 38 72.26 
Controls  100 72.56 
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VII. QTc MEAN IN TYPE 2 DIABETES MELLITUS PATIENTS AND 
CONTROLS 
                     Among the Type 2 Diabetes Mellitus patients and controls 
QTc mean was found to be significantly high in diabetic patients with 
Grade 2 CAN. There was no significant difference in QTC mean values 
between diabetics without CAN and healthy controls . 
 
Table 7: QTc Mean in Type 2 Diabetes Mellitus patients and controls 
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Mean in Type 2 
Diabetes 
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patients and 
controls 
Group  Number of patients Mean QTc mean  
Cases -Grade 2 CAN 44 425.64 
Cases- Grade 1 CAN 18 402.22 
Cases- Grade 0 CAN 38 390.32 
Controls  100 387.57 
425.64              402.22             390.32                387.57             
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VIII. QTc MAXIMUM IN TYPE 2 DIABETES MELLITUS PATIENTS 
AND CONTROLS 
                                                Among the Type 2 Diabetes Mellitus patients 
and controls QTc max was found to be significantly high in diabetic 
patients with Grade 2 CAN.  QTc max was found to be higher in diabetics 
with Grade 1 or 0 CAN compared to controls 
 
Table 8: QTc Maximum in Type 2 Diabetes Mellitus patients and controls. 
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Group  Number of patients Mean QTc maximum 
Cases- Grade 2 CAN 44 452.91 
Cases- Grade 1 CAN 18 420.89 
Cases- Grade 0 CAN 38 406.74 
Controls  100 400.80 
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IX. QTc MINIMUM IN TYPE 2 DIABETES MELLITUS PATIENTS 
AND CONTROLS 
                                       Among the Type 2 Diabetes Mellitus patients and 
controls QTc minimum was found to be significantly high in diabetic 
patients with Grade 2 CAN. There was no significant difference in QTc 
minimum values between diabetics without CAN and healthy controls . 
 
Table 9: QTc Minimum in Type 2 Diabetes Mellitus patients and controls 
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Group  Number of patients Mean QTc minimum 
Cases- Grade 2 CAN 44 398.36 
Cases- Grade 1 CAN 18 383.56 
Cases- Grade 0 CAN 38 373.89 
Controls  100 374.58 
Figure 9 : QTc 
Minimum in 
Type 2 Diabetes 
Mellitus 
patients and 
controls 
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X. QTc DISPERSION IN TYPE 2 DIABETES MELLITUS PATIENTS 
AND CONTROLS 
                                    
                              Among the Type 2 Diabetes Mellitus patients and 
controls QT dispersion  was found to be significantly high in diabetic 
patients with Grade 2 CAN. QTd  was found to be high in diabetics with 
Grade 1 CAN compared to controls 
 
Table 10: QTd in Type 2 Diabetes Mellitus patients and controls. 
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Group  Number of patients Mean QTd 
Cases- Grade 2 CAN 44 54.09 
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ANALYSIS OF RESULTS 
STATISTICAL ANALYSIS 
                                        The information collected regarding all selected cases were 
recorded in master chart. Data analysis was done with the help of computer using 
Statistical Package for Social Sciences(SPSS) software developed by IBM 
Corporation. Using this software percentage, mean, standard deviation and p value 
were calculated through Pearson correlation and Student t test and p value of < 0.05 
was taken as significant. 
 
                      In this study the association between QTc mean, QTc maximum 
,QTc minimum, QTc mean ,QT dispersion and severity of CAN was studied among 
Type 2 Diabetes Mellitus patients and controls. 
.  
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I. RELATION BETWEEN DURATION OF DIABETES AND CAN 
 
Among 81 patients with Type 2 Diabetes Mellitus with duration of diabetes  
5-10 years ,35 patients had no features of CAN. 18 patients had Grade 1 CAN ,28  
patients had Grade 2 CAN. Among the study group 16 patients had duration of 
diabetes 10-15 years.Of these patients, 3 had no features of CAN, 13 had Grade 2 
CAN. Among 3 patients with disease duration more than 15 years, 3 had Grade 2 
CAN. The incidence of CAN and its severity found to be higher with longer duration 
of the disease with a correlation coefficient of 0.520. 
 
Table 1: Correlation between duration of diabetes and CAN  
Duration in 
years 
No. of cases Grade 0 Grade 1 Grade 2 
5-10 years 81 35 18 28 
11-15 years 16 3 0 13 
>15 years 3 0 0 3 
 
                                   Correlation coefficient- 0.520           : High Correlation 
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Figure 1: Diagram showing Correlation between duration of diabetes and CAN 
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II. CORRELATION BETWEEN SEVERITY OF DIABETES AND CAN 
 
Among 76 patients with PPBS <250mg/dl, 20 had Grade2 CAN, 18 had  
Grade 1 CAN and 38 had no features of CAN. Of 6 patients with PPBS between 250-
300 mg/dl , all of them had Grade 2 CAN. Out of 18 patientswith PPBS> 300 mg /dl 
all of them had Grade 2 CAN.On analysing the data , Pearson correlation coefficient is 
found to be 0.717 , which indicates high correlation. 
 
Table 2. Correlation between severity of diabetes and CAN 
PPBS in mg/dl No. of cases Grade 0 Grade 1 Grade 2 
<250mg/dl 76 38 18 20 
250-300 mg/dl 6 0 0 6 
>300 mg/dl 18 0 0 18 
 
                                   Correlation coefficient- 0.717           : High Correlation 
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Figure 2 : Diagram showing Correlation between severity of diabetes and CAN 
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III. COMPARISON OF HEART RATE BETWEEN STUDY GROUP 
AND CONTROL GROUP 
 
                              The resting heart rate of Type 2 diabetic patients was compared 
with healthy controls . It was found that mean resting heart rate was significantly more 
in study group than control group(p<0.01). Within the study group mean resting heart 
rate was found to be significantly more in patients with autonomic neuropathy than in 
patients without autonomic neuropathy     ( p<0.01). Among those with autonomic 
neuropathy mean resting heart rate was found to be significantly more in patients with 
Grade 2 CAN than those with Grade 1 CAN(p<0.01).There was no significant 
difference in mean heart rate among diabetic patients without autonomic neuropathy 
and healthy controls(p=0.110). 
 
Table 3. Mean Heart rate in study and control groups  
 
Group  Heart rate   
Grade 2 CAN 92.68  
Grade 1 CAN 76.78  
Grade 0 CAN 72.26  
Control gp 72.56  
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Figure 3: Diagram showing Mean Heart rate in study and control groups. In the study 
group mean resting heart rate was found to be 92.68 in patients with Grade 2 CAN 
and 76.78 in those with Grade 1 CAN and 72.78 in diabetic patients without 
autonomic neuropathy and 72.56 in healthy controls. 
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IV. COMPARISON OF QTc MAXIMUM BETWEEN STUDY GROUP 
AND CONTROL GROUP 
 
                              The QTc maximum of Type 2 diabetic patients was compared with 
healthy controls . It was found that QTc maximum was significantly more in cases 
than controls (p<0.01). Within the study group QTc maximum was found to be 
significantly more in patients with CAN than in patients without CAN( p<0.01). 
Among those with CAN QTc maximum was found to be significantly more in patients 
with Grade 2 CAN than those with Grade 1 CAN(p<0.01).There was no significant 
difference in QTc maximum among diabetic patients without CAN and healthy 
controls(p=0.061). 
 
 
Table 4. QTc maximum in study and control groups  
 
Group  QTc maximum (ms)   
Grade 2 CAN 452.91  
Grade 1 CAN 420.89  
Grade 0 CAN 406.74  
Control gp 400.80  
78 
 
 
Figure 4 : Diagram showing QTc maximum in study and control groups . QTc 
maximum values were 452.91 msec, 420.89 msec, 406.74msec  and 400.80 msec, 
respectively in the four groups. Difference between the groups were statistically 
significant except that there was no statistically significant difference in QTc 
maximum value among diabetics without autonomic neuropathy and controls .QTc 
maximum in the severe autonomic neuropathy group (452.91 msec) was significantly 
more than that in early neuropathy group (420.89 msec). 
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V. COMPARISON OF QTc MINIMUM BETWEEN STUDY GROUP 
AND CONTROL GROUP 
 
                              The QTc minimum of Type 2 diabetic patients was compared with 
healthy controls . It was found that QTc minimum was significantly more in study 
group than control group (p<0.01). Within the study group QTc minimum was found 
to be significantly more in patients with CAN than in patients without CAN( p<0.01). 
Unlike QT maximum ,QT minimum did not show statistically significantly difference 
between patients with Grade 2 CAN and  those with Grade 1 CAN(p=0.275).There 
was no significant difference in QTc minimum among diabetic patients without CAN 
and healthy controls(p=0.929). 
 
 
Table 5. QTc minimum in study and control groups  
 
Group  QTc minimum (ms)   
Grade 2 CAN 398.36  
Grade 1 CAN 383.56  
Grade 0 CAN 373.89  
Control gp 374.58  
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Figure 5 : Diagram showing QTc minimum in study and control groups.                       
QTc minimum values were 398.36 msec, 383.56 msec, 373.89msec and 374.58 msec, 
respectively in the four groups. Difference between the groups were statistically 
significant except that there was no statistically significant difference in QTc 
minimum value among diabetics without autonomic neuropathy and controls. QTc 
minimum in the severe autonomic neuropathy group (398.36 msec) and in early 
neuropathy group (383.56 msec). 
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VI. COMPARISON OF QTc MEAN BETWEEN STUDY GROUP AND 
CONTROL GROUP 
 
                              The QTc mean of Type 2 diabetic patients was compared with 
healthy controls . It was found that QTc mean was significantly more in study group 
than control group (p<0.01). Within the study group QTc mean was found to be 
significantly more in patients with CAN than in patients without CAN( p<0.01). 
Among those with CAN QTc mean was found to be significantly more in patients 
with Grade 2 CAN than those with Grade 1 CAN(p<0.01).There was no significant 
difference in QTc mean among diabetic patients without CAN and healthy 
controls(p=0.348). 
 
Table 6. QTc mean in study and control groups  
 
Group  QTc mean (ms)   
Grade 2 CAN 425.64  
Grade 1 CAN 402.22  
Grade 0 CAN 390.32  
Control gp 387.57  
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Figure 6:  Diagram showing QTc mean in study and control groups. QTc mean in the 
four groups were 425.64 msec, 402.22 msec, 390.32 and 387.57 msec, respectively. 
The difference between autonomic neuropathy and no autonomic neuropathy group 
was statistically significant. But there was no statistically significant difference in QTc 
mean value among diabetics without autonomic neuropathy and controls. 
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VII. COMPARISON OF QT DISPERSION BETWEEN STUDY GROUP 
AND CONTROL GROUP 
 
                              The QT dispersion of Type 2 diabetic patients was compared with 
healthy controls . It was found that QT dispersion was significantly more in study 
group than control group (p<0.01). Within the study group QT dispersion was found 
to be significantly more in patients with CAN than in patients without CAN( p<0.01). 
Among those with CAN QT dispersion was found to be significantly more in patients 
with Grade 2 CAN than those with Grade 1 CAN(p<0.01). Unlike other parameters 
QTd showed significant difference between diabetics without autonomic neuropathy 
and healthy controls(0.024). 
 
Table 7. QT dispersion in study and control groups  
 
Group  QT dispersion (ms)   
Grade 2 CAN 54.09  
Grade 1 CAN 37.11  
Grade 0 CAN 33.11  
Control gp 26.48  
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Figure 7 :  Diagram showing QT dispersion in study and control groups. QTc 
dispersion in the case group with severe diabetic autonomic neuropathy was 54.09 
msec ,compared to 37.11 msec in diabetics with early  autonomic neuropathy ;33.11 
msec in diabetics without autonomic neuropathy ;and 26.48 in healthy controls. The 
difference was statistically very significant. In contrast to other parameters QTc 
dispersion was found to be significantly more in diabetics without autonomic 
neuropathy than healthy controls making it an even more sensitive parameter. 
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DISCUSSION 
                        The present study findings are consistent with and correlate those of 
prior studies documenting that ECG can be used as a bedside tool to assess the 
presence of CAN in Type 2 diabetes mellitus patients. 
                      In this study QTc mean and QTc maximum, QTc minimum and QTc 
dispersion values were measured in the severe and early autonomic neuropathy group 
and compared with no autonomic neuropathy group and controls. QTc mean in the 
four groups were 425.64 msec, 402.22 msec, 390.32 and 387.57 msec, respectively. 
The difference between autonomic neuropathy and no autonomic neuropathy group 
was statistically significant. But there was no statistically significant difference in QTc 
mean value among diabetics without autonomic neuropathy and controls. 
                     Similarly, QTc maximum values were 452.91 msec, 420.89 msec, 
406.74msec  and 400.80 msec, respectively in the four groups. Difference between the 
groups were statistically significant except that there was no statistically significant 
difference in QTc maximum value among diabetics without autonomic neuropathy 
and controls .QTc maximum in the severe autonomic neuropathy group (452.91 msec) 
was significantly more than that in early neuropathy group (420.89 msec). In our 
study, 79% of severe autonomic neuropathy patients ie 35 patients out of 44 with 
severe CAN had QTc maximum more than 440 msec. In the previous study by 
Germandy G et al.,  QTc intervals in definite CAN was 456msec, and in early-
435msec, and without  CAN-413msec.                 
                       QTc minimum values were 398.36 msec, 383.56 msec, 373.89msec and 
374.58 msec, respectively in the four groups. Difference between the groups were 
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statistically significant except that there was no statistically significant difference in 
QTc minimum value among diabetics without autonomic neuropathy and controls. 
Unlike other parameters QTc minimum did not show significant difference between 
patients with Grade 2(398.36 msec)  and Grade 1 CAN(383.56 msec). 
                          Diabetic patients with CAN showed an increase in QTc dispersion in 
our study that correlates with cardiac adrenergic dysinnervation .Increased QT 
dispersion was  demonstrated in diabetic patients during episodes of hypoglycemia. In 
our study, QTc dispersion in the case group with severe diabetic autonomic 
neuropathy was 54.09 msec ,compared to 37.11 msec in diabetics with early  
autonomic neuropathy ;33.11 msec in diabetics without autonomic neuropathy ;and 
26.48 in healthy controls. The difference was statistically very significant. In contrast 
to other parameters QTc dispersion was found to be significantly more in diabetics 
without autonomic neuropathy than healthy controls making it an even more sensitive 
parameter. Normal QT dispersion is <50 msec. 47% of the severe autonomic 
neuropathy group ie 21 out of 44 patients with severe autonomic neuropathy had QTc 
dispersion of more than 50 msec. Since all other factors which may cause 
prolongation of  QTc were ruled out in this study group, the prolonged QTc intervals 
in our group can be considered to be be due to autonomic dysfunction. 
                      In addition ,in the early stages of autonomic neuropathy , when the 
patient is asymptomatic and diagnosis of autonomic neuropathy can be made out only 
by doing cumbersome autonomic function tests, our study showed that QT dispersion, 
QT minimum, QT maximum and QT mean helped in the identification of such 
patients . The present study showed that QT dispersion, QT minimum, QT maximum 
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and QT mean was significantly more in diabetics with early diabetic neuropathy and 
controls.  
                                      Diagnosing patients with early autonomic neuropathy is very 
important ,since aggressive management by lifestyle modification and strict glycemic 
control helps in delaying the progression of CAN in such patients. QT dispersion was 
found to be a even more sensitive indicator, as it was found to be higher in diabetic 
patients without CAN compared to healthy controls. 
 
LIMITATIONS OF THE STUDY  
i. Lack of clinical follow-up data so the influence of CAN on mortality of 
diabetic patients with severe CAN including sudden cardiac death were not 
assessed 
ii. Ischemic heart disease was not ruled out by coronary angiography                   
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CONCLUSIONS 
 
            Diabetics with CAN had significantly higher QTc mean, QTc maximum ,QTc  
            minimum values compared to diabetics without CAN and controls . 
 
QTc dispersion was significantly more among patients with CAN compared to   
those without CAN and controls . 
 
QTc mean, QTc maximum ,QTc dispersion values were significantly more 
among patients with severe CAN compared to early CAN. 
 
QTc minimum values were not significantly different among patients with       
Severe vs. Early CAN.  
  
QTc dispersion values were significantly different among patients without   
CAN and controls.  
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LIST OF ABBREVIATIONS 
DM   -DIABETES MELLITUS 
CAN   -CARDIAC AUTONOMIC NEUROPATHY 
CART  -CARDIAC AUTONOMIC REFLEX TESTS 
MODY  -MATURITY ONSET DIABETES OF YOUNG 
HNF   - 
BMI   -BODY MASS INDEX 
PCOS  -POLYCYSTIC OVARIAN SYNDROME 
HDL   -HIGH DENSITY LIPOPROTEIN 
GDM   -GESTATIONAL DIABETES MELLITUS 
IFG   -IMPAIRED FASTING GLUCOSE 
IGT   -IMPAIRED GLUCOSE TOLERANCE 
CVD   -CARDIOVASCULAR DISEASE 
PG   -PLASMA GLUCOSE 
DKA   -DIABETIC KETOACIDOSIS 
HHS   -HYPEROSMOLAR HYPERGLYCEMIC STATE 
AGE‘s  -ADVANCED GLYCOSYLATION END PRODUCTS 
BRS   -BAROREFLEX SENSITIVITY 
HRV   -HEART RATE VARIABILITY 
LV   -LEFT VENTRICLE 
HR   -HEART RATE 
MSNA  -MUSCLE NERVE SYMPATHETIC NERVE ACTIVITY 
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MBF   -MEAN BLOOD FLOW 
MI   -MYOCARDIAL INFARCTION 
RAAS  -RENIN ANGIOTENSIN ALDOSTERONE SYSTEM 
GLP   -GLUCAGON LIKE PEPTIDE 
DPP   -DIPEPTIDYL PEPTIDASE 
ACEI   -ANGIOTENSIN CONVERTING ENZYME INHIBITOR 
QTd   -QT DISPERSION 
QTc   -CORRECTED QT 
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PROFORMA 
Name: 
Age / Sex: 
IP no: 
Occupation: 
Presenting complaints: 
Past History: 
Personal history 
alcoholic/ non alcoholic 
smoker/ nonsmoker 
Clinical Examination: 
General Examination:Consciousness, orientation,febrile/afebrile, Pallor, 
jaundice, Clubbing, Lymphadenopathy, pedal edema. 
Vitals: 
PR 
BP 
MEAN RESTING HEART RATE 
100 
 
RR 
SPO2 
Systemic examination: 
CVS: 
RS: 
ABDOMEN: 
CNS: 
Laboratory investigations: FBS, PPBS, Urine albumin,Serum Creatinine 
CAN GRADE: 
ECG:  QT interval, QTc, QT maximum, QT minimum, QT mean, QT 
dispersion 
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MASTER CHART 
CASE GROUP 
Sl.n
o. 
Age Sex Duration 
of 
diabetes 
Heart  
rate 
FBS PPBS CAN 
grade 
QTc 
mean 
QT 
max 
QT 
min 
QT
d 
1 72 M 12 98 160 340 severe 440 464 416 48 
2 62 M 10 96 189 320 severe 436 460 412 48 
3 45 M 6 66 122 187 nil 396 404 388 16 
4 48 M 7 76 140 220 early 400 412 388 24 
5 65 F 9 92 140 220 severe 428 452 404 48 
6 55 F 15 96 180 340 severe 424 444 404 40 
7 50 M 6 72 116 168 nil 384 396 372 24 
8 60 M 6 76 112 200 nil 412 428 396 32 
9 45 F 6 88 142 200 severe 408 440 376 64 
10 48 F 10 90 200 340 severe 392 424 360 64 
11 52 F 5 70 132 188 early 400 412 388 24 
12 55 M 7 70 110 132 nil 408 416 400 16 
13 42 M 5 70 120 148 nil 392 400 384 16 
14 56 M 8 96 180 340 severe 404 448 360 68 
15 58 F 9 98 132 198 severe 416 460 372 88 
16 49 M 5 94 180 360 severe 420 436 404 32 
17 44 F 5 70 134 200 early 388 420 356 64 
18 65 F 10 102 180 320 severe 428 464 392 72 
19 45 M 5 66 112 160 nil 376 396 356 40 
20 66 F 12 88 112 180 severe 432 468 396 72 
21 62 M 11 80 90 130 nil 376 396 356 40 
22 65 M 12 70 110 140 nil 380 400 360 40 
23 56 M 8 88 160 220 severe 428 456 400 56 
24 55 F 9 72 124 200 early 392 424 360 64 
25 54 M 15 96 180 240 severe 432 456 408 48 
26 54 M 8 70 130 180 nil 388 404 372 32 
27 53 F 8 92 160 340 severe 420 460 380 80 
28 50 F 6 72 120 160 nil 388 400 376 24 
29 46 F 5 70 130 200 early 400 412 388 24 
30 66 M 20 106 120 320 severe 440 468 412 56 
31 45 M 5 72 112 180 nil 400 416 384 32 
32 50 M 5 66 120 180 nil 380 408 352 56 
33 55 M 7 110 150 240 severe 396 436 356 80 
34 52 M 6 88 112 148 nil 412 420 404 16 
35 50 M 6 88 140 180 early 416 428 404 24 
36 53 M 9 98 180 240 severe 416 448 384 64 
37 54 F 11 100 190 320 severe 428 468 388 80 
38 57 F 6 70 112 140 nil 396 400 392 8 
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39 47 F 5 70 96 150 nil 380 396 364 34 
40 55 M 8 98 160 220 severe 432 452 412 40 
41 58 M 9 102 230 320 severe 436 464 408 56 
42 45 F 6 80 110 146 nil 376 396 356 40 
43 54 F 6 80 128 200 early 392 412 372 40 
44 48 M 7 78 120 200 nil 388 400 376 24 
45 44 M 5 76 110 130 nil 404 408 400 8 
46 60 M 11 88 130 200 severe 436 452 420 32 
47 56 F 8 82 140 180 early 412 424 400 24 
48 58 M 7 78 150 200 nil 376 396 356 40 
49 60 F 10 70 130 180 early 392 412 372 40 
50 48 F 8 90 220 340 severe 424 468 380 88 
51 44 M 5 70 130 260 nil 392 404 380 24 
52 48 F 7 92 160 240 severe 416 452 380 72 
53 48 M 5 66 140 200 nil 400 412 388 24 
54 56 F 10 90 220 360 severe 420 444 396 48 
55 52 M 8 82 120 156 early 404 420 388 32 
56 54 F 10 88 156 220 severe 432 448 416 32 
57 59 F 7 70 112 136 nil 408 416 400 16 
58 49 M 6 76 130 180 early 408 420 396 24 
59 55 F 5 66 100 140 nil 380 396 364 32 
60 67 F 15 88 190 280 severe 436 460 412 48 
61 56 M 7 60 160 200 nil 376 392 360 32 
62 86 F 22 90 242 292 severe 432 460 404 56 
63 58 F 8 76 112 156 nil 384 400 368 32 
64 60 M 9 78 132 180 early 404 424 384 40 
65 57 F 8 88 140 200 early 408 428 388 40 
66 60 M 12 98 148 240 severe 428 456 400 56 
67 58 M 14 96 240 360 severe 432 464 400 64 
68 56 M 12 100 200 240 severe 436 460 412 48 
69 54 F 9 78 212 292 severe 420 440 400 40 
70 64 F 16 72 200 220 severe 440 468 412 56 
71 60 M 6 70 140 190 nil 392 396 388 16 
72 46 M 5 88 180 240 severe 416 436 396 40 
73 44 M 5 80 100 160 nil 400 416 384 32 
74 60 M 7 76 220 240 nil 376 396 356 40 
75 56 F 8 74 240 360 severe 432 448 416 32 
76 55 M 8 70 116 140 nil 380 400 360 40 
77 54 M 6 78 140 156 early 404 432 376 56 
78 45 F 5 72 160 200 early 408 432 384 48 
79 48 F 5 92 160 200 severe 432 452 412 40 
80 56 M 8 96 100 180 severe 416 436 396 40 
81 56 F 7 70 130 180 nil 400 440 360 80 
82 52 M 8 92 200 320 severe 428 452 404 48 
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83 54 M 9 90 180 260 severe 436 464 408 56 
84 67 F 12 88 280 360 severe 416 440 392 48 
85 61 M 10 66 160 240 nil 380 404 356 48 
86 49 F 5 68 140 200 early 392 412 372 36 
87 52 F 6 66 140 180 nil 392 404 380 24 
88 54 M 5 70 112 168 nil 376 396 356 40 
89 56 F 9 88 190 320 severe 420 440 400 40 
90 48 M 6 92 160 280 severe 428 452 404 48 
91 48 M 8 90 140 180 early 408 424 392 32 
92 48 M 9 92 160 220 nil 404 412 396 16 
93 55 F 12 98 200 268 severe 436 456 416 40 
94 52 F 15 88 180 240 severe 440 464 416 48 
95 50 F 8 94 160 200 severe 420 448 392 56 
96 56 M 5 72 132 176 early 412 428 396 32 
97 58 M 6 70 112 148 nil 396 416 376 40 
98 48 M 6 70 140 180 nil 400 428 372 56 
99 45 F 6 72 130 180 nil 384 412 356 56 
100 46 F 7 76 110 140 nil 400 436 364 72 
 
 
 
 
CONTROL GROUP 
Sl.n
o. 
Age Sex Duration 
of 
diabetes 
Heart 
 rate 
FBS PPBS CAN 
grade 
QTc 
mean 
QT 
max 
QT 
min 
QT
d 
1 58 M 0 72 82 120 0 422 424 420 24 
2 45 F 0 76 90 100 0 414 428 400 28 
3 54 F 0 80 78 90 0 362 384 352 32 
4 48 M 0 66 88 110 0 378 396 360 36 
5 44 M 0 56 100 120 0 382 392 372 20 
6 60 M 0 72 96 114 0 388 400 376 24 
7 56 F 0 66 92 112 0 384 400 368 32 
8 58 M 0 64 78 90 0 370 384 356 28 
9 60 F 0 62 88 130 0 380 392 368 24 
10 48 F 0 70 100 120 0 402 416 388 28 
11 44 M 0 80 78 112 0 408 424 392 32 
12 52 F 0 88 80 114 0 370 388 352 36 
13 50 F 0 92 78 116 0 382 392 372 20 
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14 56 M 0 56 98 118 0 384 396 372 24 
15 58 M 0 68 96 110 0 392 408 376 32 
16 48 M 0 62 68 104 0 418 428 408 20 
17 45 F 0 80 84 98 0 372 384 360 24 
18 46 F 0 70 82 96 0 380 396 364 32 
19 72 M 0 76 90 110 2 372 392 364 28 
20 62 M 0 74 92 100 0 388 400 376 24 
21 45 M 0 58 98 90 0 386 400 372 28 
22 48 M 0 60 96 120 0 372 384 360 24 
23 65 F 0 76 86 130 1 378 392 364 28 
24 65 M 0 72 94 120 0 400 416 384 32 
25 56 M 0 70 84 140 0 374 392 356 36 
26 55 F 0 80 86 126 0 406 416 396 20 
27 54 M 0 86 88 110 0 412 424 400 24 
28 54 M 0 84 100 120 0 370 388 352 36 
29 53 F 0 58 96 114 0 382 392 372 20 
30 50 F 0 56 92 112 0 384 396 372 24 
31 46 F 0 60 78 90 0 392 408 376 32 
32 66 M 0 60 88 130 1 418 428 408 20 
33 56 F 0 66 100 120 0 372 384 360 24 
34 55 M 0 64 78 112 0 386 396 376 20 
35 54 M 0 68 80 114 0 380 392 368 24 
36 45 F 0 72 78 116 0 380 396 364 32 
37 48 F 0 64 98 118 0 380 392 368 28 
38 56 M 0 62 68 104 0 388 400 376 24 
39 56 F 0 68 84 98 0 386 400 372 28 
40 52 M 0 86 82 96 0 368 384 352 32 
41 54 M 0 80 90 110 0 374 392 356 36 
42 56 F 0 90 92 100 0 406 416 396 20 
43 48 M 0 74 98 90 0 412 424 400 24 
44 48 M 0 72 96 120 0 372 388 356 32 
45 50 M 0 72 86 130 0 382 392 372 20 
46 55 M 0 70 94 120 0 384 396 372 24 
47 52 M 0 66 84 140 0 394 408 380 28 
48 50 M 0 76 86 126 0 412 428 396 32 
49 53 M 0 74 88 110 0 371 392 350 36 
50 54 F 0 72 96 120 0 386 396 376 20 
51 57 F 0 88 86 130 0 396 408 384 24 
52 47 F 0 80 94 120 0 410 428 392 36 
53 55 M 0 84 84 140 0 374 384 364 20 
54 45 M 0 76 86 126 0 384 396 372 24 
55 48 M 0 66 88 110 0 376 392 360 32 
56 65 F 0 64 100 120 0 390 400 380 20 
57 55 F 0 68 96 114 0 388 400 376 24 
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58 50 M 0 86 92 112 0 374 384 364 20 
59 60 M 0 74 78 90 0 380 392 368 24 
60 45 F 0 72 88 130 0 404 416 392 24 
61 48 F 0 70 100 120 0 376 392 360 32 
62 52 F 0 70 90 110 0 410 424 396 28 
63 55 M 0 66 92 100 0 416 428 404 24 
64 42 M 0 64 98 90 0 370 384 356 28 
65 56 M 0 80 96 120 0 380 396 364 32 
66 45 M 0 78 86 130 0 374 392 356 36 
67 50 M 0 84 94 120 0 390 400 380 20 
68 55 M 0 82 84 140 0 388 400 376 24 
69 52 M 0 80 86 126 0 368 384 352 32 
70 50 M 0 66 88 110 0 382 392 372 20 
71 53 M 0 76 96 120 0 404 416 392 24 
72 54 F 0 64 86 130 0 410 424 396 28 
73 57 F 0 62 90 110 0 372 388 356 32 
74 47 F 0 90 92 100 0 374 392 356 36 
75 55 M 0 88 98 90 0 386 396 376 20 
76 58 M 0 82 96 120 0 396 408 384 24 
77 45 F 0 58 86 130 0 418 428 408 20 
78 60 F 0 66 94 120 0 372 384 360 24 
79 48 F 0 64 84 140 0 380 396 364 32 
80 44 M 0 66 86 126 0 382 392 372 20 
81 48 F 0 80 88 110 0 388 400 376 24 
82 48 M 0 88 96 120 0 390 400 380 20 
83 56 F 0 74 86 130 0 384 396 372 24 
84 52 M 0 76 94 120 0 404 416 392 24 
85 54 F 0 82 84 140 0 408 424 392 32 
86 59 F 0 80 86 126 0 374 388 360 28 
87 49 M 0 76 88 110 0 382 392 372 20 
88 58 F 0 74 100 120 0 384 396 372 24 
89 60 M 0 70 96 114 0 396 408 384 24 
90 57 F 0 66 86 126 0 411 428 394 32 
91 60 M 0 68 88 110 0 370 384 356 28 
92 58 M 0 90 96 120 0 384 396 372 24 
93 56 M 0 64 86 130 0 378 392 364 28 
94 54 F 0 66 90 110 0 384 400 368 32 
95 64 F 0 80 92 100 0 382 400 364 36 
96 60 M 0 78 98 90 0 382 392 372 20 
97 46 M 0 80 96 120 0 404 416 392 24 
98 46 F 0 66 88 110 0 410 420 400 20 
99 52 M 0 68 96 120 0 377 384 370 24 
100 66 M 0 70 86 130 1 386 396 376 20 
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